Given the established link between G6PC1 expression levels and HCC patient survival, as well as its correlation with immune cell presence, it is plausible to suggest that G6PC1 might influence HCC prognosis through interactions with specific immune cell populations. This evidence concerns the gene G6PC1 and hepatocellular carcinoma.